Filter announcements
Loading...
Gennex Laboratories Ltd manufactures Bulk Drugs and IntermediariesBusiness Overview: GLL is an ISO 9001:2008, TUV, ISO 14001 and OSHAS 18000 certified vertically integrated Active Pharmaceutical Ingredient manufacturer & exporter of Bulk Drugs, Intermediates and Biotech Products in the form of Expectorants, Muscle Relaxants, Analgesic and Anti Fungal, etc.
Gennex Laboratories Limited has announced a board meeting on August 14. The primary agenda is to consider and approve the financial results for the quarter ended June 30. This is a key event for investors, as these results will provide crucial insights into the company's operational performance and financial health...
Gennex Laboratories' subsidiary, Deccan Remedies, has secured manufacturing approval from the Andhra Pradesh Drug Control Administration. This license allows Deccan Remedies to produce and sell a wide range of 42 pharmaceutical products for both domestic and export markets. This development significantly expands the subsidiary's product portfolio and manufacturing capabilities, directly...
Gennex Laboratories has announced a special, time-limited opportunity for shareholders to resubmit previously rejected requests for physical share transfers. This initiative addresses past rejections that occurred due to reasons like signature mismatches or other procedural issues, ensuring that upon successful processing, shares are credited only in dematerialized form. This is...
Gennex Laboratories has submitted a compliance certificate from its Registrar and Transfer Agent for the quarter ended June 30, 2025. This document confirms the company's robust process for handling shareholder dematerialisation requests. All physical share certificates received were promptly converted into electronic form, verified, and records updated accurately. This ensures...
Gennex Laboratories Limited has announced a board meeting to consider the financial results for the quarter and half-year. For the year ended March 31, 2025, the standalone total income was Rs 95,930.05 lakh, with a net profit of Rs 17,061.16 lakh after tax. The consolidated total income stood at Rs...